NEVVI Medicare utilization intelligence
or

← back

Provider profile

DADLA, ALIAKBAR M.D.

Medical Oncology · NPI 1134474976 · VANCOUVER, WA

1
Groups
45
Codes · 2024
69,567
Disclosed services

DADLA, ALIAKBAR is a Medical Oncology in VANCOUVER, WA, a member of 1 medical group, who billed 45 distinct codes to Medicare Part B in 2024.

Groups: NORTHWEST MEDICAL SPECIALTIES PLLC (TACOMA, WA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

69,567
disclosed services
45
codes billed to Medicare Part B
Prior year · CY2023 50,042 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
J1453 Injection, fosaprepitant, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96413 Administration of chemotherapy into vein, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96375 Injection of additional new drug or substance into vein
J2405 Injection, ondansetron hydrochloride, per 1 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J3489 Injection, zoledronic acid, 1 mg
96372 Injection of drug or substance under skin or into muscle
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J9045 Injection, carboplatin, 50 mg
96415 Administration of chemotherapy into vein, each additional hour
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
80053 Blood test, comprehensive group of blood chemicals
96417 Administration of additional new drug or substance into vein, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
96361 Infusion into a vein for hydration, each additional hour
96360 Infusion into a vein for hydration, 31-60 minutes
82728 Ferritin (blood protein) level
J7030 Infusion, normal saline solution , 1000 cc
96411 Administration of additional new drug or substance into vein using push technique
J3490 Unclassified drugs
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
99195 Drawing of blood for a medical problem
99443 Telephone medical discussion with physician, 21-30 minutes
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
98980 Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month
96374 Injection of drug or substance into vein
96523 Irrigation of implanted venous access drug delivery device
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
83540 Iron level
84466 Transferrin (iron binding protein) level

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.